TabsDetailsBasic DetailsDate: Monday, November 14, 2016Type: PublicationMedical Product: non-steroidal anti-inflammatory drug (NSAID)Health Outcome(s): gastrointestinal hemorrhageperforated ulcerDescription: The objective of this study was to evaluate whether hemoglobin results increase UGI outcome identification in electronic databases, using non-steroidal anti-inflammatory drugs (NSAIDs) as a test case. Read More Materials: Drug Safety; Volume 40, Issue 1, 15 November 2016, Pages 91-100; DOI:10.1007/s40264-016-0472-3Additional InformationRelated Assessment(s): Analytic Methods for Using Laboratory Test Results In Active Database Surveillance2016 ICPE Poster: Do Hemoglobin Lab Test Results Increase Detection of Upper Gastrointestinal Bleeding (UGIB)?ContributorsAuthor(s): Elisabetta Patorno MD, DrPH; Joshua Gagne PharmD, ScD; Christine Lu PhD, MSc; Kevin Haynes PharmD, MSCE; Andrew Sterret PhD; Jason Roy PhD; Marsha Raebel PharmD; Xingmei Wang MSCorresponding Author: E. Patorno, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine Brigham and Women’s Hospital and Harvard Medical School, Boston, USA. Email: epatorno@partners.org
